Back

Incidence and outcomes of new and persistent use of proton pump inhibitors following percutaneous coronary intervention: a retrospective population-based study

30 August 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (2) - Acute coronary syndromes and pharmacotherapy Adjunctive Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Leon Arnar Heitmann

Reykjavik (Iceland)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor N. Herity (Belfast, GB)
Abstract Slides Video
Presentation thumbnail
Professor Y. Kim (Chuncheon, KR)
Abstract Slides Video
Presentation thumbnail
Doctor S. An (Seoul, KR)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (2) - Acute coronary syndromes and pharmacotherapy

The Event

Event poster

ESC Congress 2025

30 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Association between reduced risk of gastrointestinal bleeding related to proton pump inhibitor use and subsequent all-cause death in patients with percutaneous coronary intervention
thumbnail
Congress Presentation
Interplay among proton pump inhibitors, platelet reactivity and CYP2C19 genotyping in clopidogrel-treated patients after drug-eluting stent implantation
thumbnail
Congress Presentation
Proton pump inhibitors in myocardial infarction: safety paradox in Type 1 vs. Type 2---a multicenter retrospective cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources